SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-008082
Filing Date
2019-02-07
Accepted
2019-02-07 16:35:27
Documents
2
Period of Report
2019-02-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1582
2 POA DOCUMENT poa.txt EX-24.3_831053 4007
  Complete submission text file 0001209191-19-008082.txt   7060
Mailing Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135
Business Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135 617-225-0096
PROTEOSTASIS THERAPEUTICS, INC. (Issuer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations

Mailing Address PROTEOSTASIS THERAPEUTICS, INC. 80 GUEST STREET, SUITE 500 BOSTON MA 02135
Business Address
Dulac Emmanuel (Reporting) CIK: 0001766812 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37695 | Film No.: 19575602